SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-133328
Filing Date
2016-11-10
Accepted
2016-11-10 16:32:43
Documents
57
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v452478_10-q.htm 10-Q 546289
2 EXHIBIT 31.1 v452478_ex31-1.htm EX-31.1 8827
3 EXHIBIT 32.1 v452478_ex32-1.htm EX-32.1 4146
  Complete submission text file 0001144204-16-133328.txt   4923413

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nwbo-20160930.xml EX-101.INS 1116271
5 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20160930.xsd EX-101.SCH 51431
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20160930_cal.xml EX-101.CAL 41639
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20160930_def.xml EX-101.DEF 348065
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20160930_lab.xml EX-101.LAB 357069
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20160930_pre.xml EX-101.PRE 366524
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 161988516
SIC: 2834 Pharmaceutical Preparations